Analytical Data
-
基因名
RG9MTD1
- Application
-
别名
tRNA methyltransferase 10 homolog C. HBV pre-S2 trans-regulated protein 2. Mitochondrial ribonuclease P protein 1. Mitochondrial RNase P protein 1. RNA (guanine-9-)-methyltransferase domain-containing protein 1. Renal carcinoma antigen NY-REN-49. mRNA methyladenosine-N(1)-methyltransferase. EC:2.1.1.-. tRNA (adenine(9)-N(1))-methyltransferase. EC:2.1.1.218. tRNA (guanine(9)-N(1))-methyltransferase. EC:2.1.1.221
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q7L0Y3
-
表达区间
1-252 aa
-
氨基酸序列
MKAAAREEAKNIKLLETTEEDKQKNFLFLRLWDRNMDIAMGWKGAQAMQFGQPLVFDMAYENYMKRKELQNTVSQLLESEGWNRRNVDPFHIYFCNLKIDGALHRELVKRYQEKWDKLLLTSTEKSHVDLFPKDSIIYLTADSPNVMTTFRHDKVYVIGSFVDKSMQPGTSLAKAKRLNLATECLPLDKYLQWEIGNKNLTLDQMIRILLCLKNNGNWQEALQFVPKRKHTGFLEISQHSQEFINRLKKAKT
-
分子量
56 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RG9MTD1 is a recombinant protein that has gained attention within the field of molecular biology and biotechnology due to its potential applications in therapeutic development and protein engineering. This protein, derived from a specific genetic sequence, has unique structural and functional properties that make it a valuable tool for studying protein interactions, cellular processes, and disease mechanisms. Research on RG9MTD1 has focused on its role in various biological pathways, including signal transduction, immune response, and cell proliferation. Additionally, RG9MTD1 is being explored for its potential as a target for drug discovery, particularly in the context of diseases such as cancer and autoimmune disorders. Scientists employ techniques such as protein expression, purification, and structural characterization to understand RG9MTD1's functional mechanisms and interactions with other biomolecules. As the demand for novel therapeutic agents continues to grow, understanding the properties and functions of proteins like RG9MTD1 is crucial for developing innovative approaches to treat complex diseases and improve healthcare outcomes. Through ongoing research, RG9MTD1 may contribute to advancements in personalized medicine and the development of targeted therapies, highlighting the importance of recombinant proteins in contemporary biomedical research.
